CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 115 filers reported holding CYMABAY THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 2.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $478,745 | +8.0% | 32,109 | -20.7% | 0.00% | 0.0% |
| Q2 2023 | $443,333 | +1036.8% | 40,487 | +282.7% | 0.00% | – |
| Q3 2021 | $39,000 | -92.5% | 10,578 | -88.3% | 0.00% | -100.0% |
| Q4 2020 | $518,000 | +1338.9% | 90,221 | +392.1% | 0.00% | – |
| Q4 2019 | $36,000 | -79.2% | 18,335 | -16.6% | 0.00% | – |
| Q4 2018 | $173,000 | -61.6% | 21,993 | -45.8% | 0.00% | – |
| Q3 2018 | $450,000 | -17.4% | 40,596 | +0.0% | 0.00% | -100.0% |
| Q2 2018 | $545,000 | – | 40,589 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 1,653,495 | $10,367,414 | 8.97% |
| Versant Venture Management, LLC | 543,753 | $3,409,330 | 7.06% |
| TCG Crossover Management, LLC | 5,905,400 | $37,026,858 | 6.54% |
| COMMODORE CAPITAL LP | 5,738,500 | $35,980 | 5.42% |
| Foresite Capital Management IV, LLC | 1,787,094 | $11,205,079 | 4.79% |
| Saturn V Capital Management LP | 1,611,778 | $5,718,432 | 4.74% |
| ACUTA CAPITAL PARTNERS, LLC | 1,015,000 | $6,364,050 | 3.92% |
| Altium Capital Management LP | 1,025,000 | $6,426,750 | 3.27% |
| Affinity Asset Advisors, LLC | 1,143,531 | $7,169,939 | 2.81% |
| GREAT POINT PARTNERS LLC | 1,550,000 | $9,718,500 | 1.90% |